✦ LIBER ✦

Outpatient studies of the safety and immunogenicity of an auxotrophic Escherichia coli K-12-Shigella flexneri 2a hybrid vaccine candidate, EcSf2a-2

✍ Scribed by David N. Taylor; Douglas F. Phillip; Michael Zapor; Andrew Trofa; Lillian Van de Verg; Antoinette Hartman; Natalie Bendiuk; John W. Newland; Samuel B. Formal; Jerald C. Sadoff; Thomas L. Hale

Book ID: 119152241
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 481 KB
Volume: 12
Category: Article
ISSN: 0264-410X
DOI: 10.1016/0264-410x(94)90318-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, immunogenicity, and efficacy in

Safety, immunogenicity, and efficacy in man of an invasive Escherichia coli K-12 hybrid vaccine expressing Shigella flexneri 2a somatic antigen

✍ K. Kotloff; D. Herrington; T. Hale; J. Newland; L. Van De Verg; S. Formal; M. Le 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Safety and immunogenicity of the oral E.

Safety and immunogenicity of the oral E. coli K12-S. flexneri 2a vaccine (EcSf2a-2) among Israeli soldiers

✍ Dani Cohen; Shai Ashkenazi; Manfred S. Green; Miri Yavzori; Nadav Orr; Raphael S 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 828 KB

Safety, dose, immunogenicity, and transm

Safety, dose, immunogenicity, and transmissibility of an oral live attenuated Shigella flexneri 2a vaccine candidate (SC602) among healthy adults and school children in Matlab, Bangladesh

✍ Kazi Mizanur Rahman; Shams El Arifeen; K. Zaman; Mahbubur Rahman; Rubhana Raqib; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Design of a Phase IIb, randomized, contr

Design of a Phase IIb, randomized, controlled, double-blind, multi-centre study to evaluate the efficacy, safety, and immunogenicity of the GMZ2 candidate malaria vaccine in Ugandan, Ghanaian, Burkinabe and Gabonese children aged 12-60 months

✍ Ramadhani A Noor, Michael Thiesen, Benjamin Mordmuller, Paul Milligan… 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 175 KB